SCHEMBL8934606

SCHEMBL8934606

COc1ccc(Cc2c(-c3ccccc3)c(=O)oc3cc(OC)ccc23)cc1

nearest known ligand 0.80

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 4/20 0.80
ESR1 P03372 5/20 0.63
ALDH1A1 P00352 7/20 0.56
CYP1A2 P05177 1/20 0.56
CYP2C9 P11712 1/20 0.56
CYP2C19 P33261 1/20 0.56
CA1 P00915 1/20 0.55
CA2 P00918 1/20 0.55
ESR2 Q92731 1/20 0.55
VKORC1 Q9BQB6 1/20 0.54
KDM4E B2RXH2 5/20 0.53
LMNA P02545 3/20 0.53
MAPT P10636 3/20 0.53
L3MBTL1 Q9Y468 1/20 0.53
TNKS O95271 1/20 0.53
SMN1; SMN2 Q16637 2/20 0.52
HPGD P15428 2/20 0.52
NQO1 P15559 1/20 0.52
GPR55 Q9Y2T6 1/20 0.52
KMT2A Q03164 3/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5142252 0.93 CYP19A1 (0.74) CYP19A1ESR1ALDH1A1CYP1A2CYP2C9
SCHEMBL8934551 0.90 VKORC1 (0.66) CYP19A1ESR1ALDH1A1CA1CA2
SCHEMBL14428676 0.90 CYP19A1 (0.68) CYP19A1ESR1ALDH1A1CYP1A2CYP2C9
SCHEMBL13183965 0.89 CYP19A1 (0.67) CYP19A1ESR1ALDH1A1CYP1A2CYP2C9
SCHEMBL13183975 0.83 ESR1 (0.68) CYP19A1ESR1ALDH1A1CYP1A2CYP2C9
SCHEMBL9957161 0.83 CYP19A1 (0.62) CYP19A1ESR1ALDH1A1CYP1A2CYP2C9
SCHEMBL5146155 0.82 CYP19A1 (0.65) CYP19A1ESR1ALDH1A1CYP2C9CYP2C19
SCHEMBL5428058 0.82 CYP19A1 (0.81) CYP19A1ESR1ALDH1A1CYP2C9CYP2C19
SCHEMBL7117813 0.82 ALDH1A1 (0.64) CYP19A1ALDH1A1CYP1A2CYP2C9CYP2C19
SCHEMBL7117556 0.82 ALDH1A1 (0.67) CYP19A1ALDH1A1CYP1A2CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1996031206-A2 FLAVONES AND COUMARINS AS AGENTS FOR THE TREATMENT OF ATHEROSCLEROSIS WARNER-LAMBERT COMPANY (US) 1996-10-10 WO disclosed